Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0019 NON-HODGKIN'S: ICE +/- Rituxan for Relapsed/Refractory CD20+ B-Cell NHL 10/15/2000 12/15/2001 2% Published
    Closed S0020 ATG for MDS 8/15/2001 5/15/2003 16%
    Closed S0022 Cis/Doc/RT followed by Consolidation Doc in NSCLC; Stage IIIB 3/15/2001 2/1/2003 33%
    Closed S0023 Cis/VP-16/RT/Consol. Doc followed by ZD1839/Placebo /IIIA & selected IIIB NSCLC 6/15/2001 4/15/2005 74% Published
    Closed S0025 OVARIAN 2/15/2003 8/15/2003 5%
    Closed S0026 IFN & Thalidomide in Disseminated Malignant Melanoma 11/1/2001 5/1/2003 62% Published
    Closed S0027 Vinorel/Doc/Adv NSCLC/Age >=70 PS 0-1/PS 2 any age; Selected IIIB & IV 9/1/2001 7/1/2003 100% Published
    Closed S0028 Advanced Bladder 7/1/2001 12/15/2006 81%
    Closed S0029 ADVANCED: Docetaxel for Metastatic Breast Cancer 8/1/2001 6/15/2005 34%
    Closed S0030 COLORECTAL 2/1/2003 2/1/2005 48% Published
    Closed S0031 Advanced Bladder 2/15/2001 10/15/2002 56% Published
    Closed S0032 Advanced Prostate 12/1/2001 6/1/2005 48% Published
    Closed S0033 Gastrointestinal Stromal Tumor 12/15/2000 9/1/2001 100% Published
    Closed S0101 ESOPHAGEAL 4/15/2001 2/1/2003 100% Published
    Closed S0102 ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Neg Stage IV Breast Cancer 5/1/2001 1/1/2004 100% Published
    Closed S0106 Phase III Starndard + Mylotarg vs. Standard + Daunomycin/Ara-C for AML Under Age 61 5/15/2004 8/20/2009 93% Published
    Closed S0107 PANCREAS 7/1/2001 6/1/2003 100% Published
    Closed S0108 NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL 4/15/2001 12/1/2004 87% Published
    Closed S0109 Advanced Renal 5/1/2001 2/1/2002 100% Published
    Closed S0111 Advanced Prostate 6/15/2001 11/15/2003 100% Published
    Scroll Table